AnaptysBio execs to present at major investor conferences in Nov-Dec 2026
Alpha Vantage · Pluang · · AI-summarised by FinFlash
AnaptysBio announced that its executive team, including CEO Daniel Faga and CFO Chris Murphy, will participate in several investor conferences in November and December 2026. These events, including the UBS Global Biopharma, Piper Sandler Healthcare, and Evercore Healthcare conferences, will feature fireside chats and investor meetings to discuss company progress and financial collaborations for products like Jemperli and Quimilza.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.